Long-term survival rates after a diagnosis of breast cancer are steadily rising. This is good
news, but clinicians must also recognize that this brings new challenges to the medical …

Venous thromboembolism (VTE) is a common complication in patients with malignant
disease. Emerging data have enhanced our understanding of cancer-associated …

Trousseau's syndrome (cancer-associated thrombosis) is the second leading cause of death
in cancer patients, after death from cancer itself. The risk of a venous thromboembolism is 4 …

Venous thromboembolism (VTE) is a significant cause of morbidity and mortality in patients
with cancer. The risk of VTE varies over the natural history of cancer, with the highest risk …

In 2 double-blind studies, ambulatory patients with objectively proven, disseminated
metastatic breast carcinoma (TOPIC-1) or stage III/IV non–small-cell lung carcinoma (TOPIC …

Venous thrombosis is the process of clot (thrombus) formation within veins. Although this
can occur in any venous system, the predominant clinical events occur in the vessels of the …

The most common medical problems in brain tumor patients include the management of
seizures, peritumoral edema, medication side effects, venous thromboembolism (VTE) …

The most frequent ultimate cause of death is myocardial arrest. In many cases this is due to
myocardial hypoxia, generally arising from failure of the coronary macro‐and …

Background: Clinical characteristics and management of acute deep vein thrombosis and
pulmonary embolism (PE) have been reported to be different in patients with and without …

Inherited hypercoagulable states, also known as thrombophilic disorders, can be caused by
loss of function of natural anticoagulant pathways or gain of function in procoagulant …